CPHRF (Cipher Pharmaceuticals) Accounts Payable: $6.50 Mil (As of Mar. 2026)


CPHRF Cipher Pharmaceuticals Inc CPHRF
96 GF Score
Price $12.06
GF Value $12.20
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Cipher Pharmaceuticals Accounts Payable?

Cipher Pharmaceuticals CPHRF +1.94% 96 Accounts Payable is $6.50 Mil as of Mar. 2026. GuruFocus rates CPHRF with a GF Score™ of 96/100 and a GF Value™ of $12.20 (Fairly Valued). The stock has 5 warning signs investors should review.

Cipher Pharmaceuticals's Accounts Payable for the quarter that ended in Mar. 2026 was $6.50 Mil.

Cipher Pharmaceuticals's quarterly Accounts Payable increased from Sep. 2025 ($4.13 Mil) to Dec. 2025 ($6.39 Mil) and increased from Dec. 2025 ($6.39 Mil) to Mar. 2026 ($6.50 Mil).

Cipher Pharmaceuticals's annual Accounts Payable increased from Dec. 2023 ($4.60 Mil) to Dec. 2024 ($5.87 Mil) and increased from Dec. 2024 ($5.87 Mil) to Dec. 2025 ($6.39 Mil).

Cipher Pharmaceuticals Accounts Payable Related Terms

Cipher Pharmaceuticals Accounts Payable Historical Data

* Premium members only.

The historical data trend for Cipher Pharmaceuticals's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cipher Pharmaceuticals Accounts Payable Chart

Cipher Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.56 4.11 4.60 5.87 6.39

Cipher Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.30 4.85 4.13 6.39 6.50
CPHRF
96GF Score
Cipher Pharmaceuticals Inc CPHRF
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cipher Pharmaceuticals Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $6.50 Mil mean?
Cipher Pharmaceuticals (CPHRF) has a Accounts Payable of $6.50 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Cipher Pharmaceuticals and its competitors.
Is Cipher Pharmaceuticals' Accounts Payable too high?
Cipher Pharmaceuticals' current Accounts Payable is $6.50 Mil. Overall, Cipher Pharmaceuticals has a GF Score™ of 96/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cipher Pharmaceuticals' Accounts Payable compare to ZTS and UTHR?
Cipher Pharmaceuticals' Accounts Payable of $6.50 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Drug Manufacturers company?
A good Accounts Payable depends on the Drug Manufacturers industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Cipher Pharmaceuticals and its competitors. Cipher Pharmaceuticals's current Accounts Payable is $6.50 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cipher Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Cipher Pharmaceuticals (CPHRF) is currently considered Fairly Valued. The stock's GF Value™ is $12.20, compared to a current price of $12.06 — trading 1.1% below its estimated fair value. The current Accounts Payable is $6.50 Mil. Cipher Pharmaceuticals' overall GF Score™ is 96/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Cipher Pharmaceuticals (CPHRF), the current Accounts Payable is $6.50 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cipher Pharmaceuticals (CPHRF) Overvalued in 2026?

Based on GuruFocus' analysis, Cipher Pharmaceuticals stock appears to be undervalued. The current stock price of $12.06 is trading 1.1% below its estimated GF Value™ of $12.20. GuruFocus considers Cipher Pharmaceuticals to be Fairly Valued.

Key valuation signals for CPHRF:

  • Accounts Payable: $6.50 Mil
  • GF Value™: $12.20 vs. price of $12.06 (1.1% below fair value)
  • GF Score™: 96/100 with 5 warning signs

No single metric tells the full story. See the CPHRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cipher Pharmaceuticals Business Description

Other Exchanges PHE:GermanyCPH:Canada
Address 5750 Explorer Drive, Suite 404, Mississauga, ON, CAN, L4W 0A9
Cipher Pharmaceuticals Inc is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products. The Company is building its business through product acquisitions, out-licensing, and in-licensing arrangements. Its products include Dermatology Products, Hospital Acute Care Products, specialty medicines, and Out-Licensed Products, among others. The company's geographical operational areas include Canada and the United States.
96GF Score

Get the complete analysis for CPHRF

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.06
Price
$12.20
GF Value